NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for D-Amphetamine


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on pharmaceuticals reported by H.M. Marston and co-researchers
2009 NOV 23 -- "Asenapine, a novel psychopharmacologic agent in the development for schizophrenia and bipolar disorder, has high affinity for serotonergic, alpha-adrenergic, and dopaminergic receptors, suggesting potential for antipsychotic and......
Subject: Pharmaceuticals
Price: $3.00
*
Findings from Curtin University of Technology provide new insights into public health
2009 NOV 24 -- "The prevalence of alcohol, tobacco and illicit drug use has been reported to be higher amongst lesbian and bisexual women (LBW) than their heterosexual counterparts. However, few studies have been conducted with this population in Australia and......
Subject: Public Health
Price: $3.00
*
Local health investigation sheds light on gastroschisis birth defect
2009 NOV 28 -- Results of an investigation conducted by University of Nevada, Reno researchers, public health officials and area physicians published this week in the Archives of Pediatrics & Adolescent Medicine, indicate that Washoe County experienced a......
Subject: University of Nevada, Reno
Price: $3.00
*
New enzyme research study findings have been reported from Florida International University
2009 NOV 2 -- According to a study from the United States, "Alcohol is the most widely abused substance and its chronic consumption causes neurobehavioral disorders. It has been shown that alcohol affects the function of immune cells."   ......
Subject: Enzyme Research
Price: $3.00
*
New findings in life sciences described from Merck & Company, Inc.
2009 NOV 23 -- "It was recently reported that administration of the metabotropic glutamate 2 and 3 (mGlu2/3) receptor agonist prodrug LY2140023 to schizophrenic patients decreased positive symptoms. However, at the single, potentially suboptimal, dose that was......
Subject: Life Sciences
View Free
Daily News
Article
New schizophrenia study findings recently were published by researchers at University of California
2009 NOV 2 -- "Bipolar mania and schizophrenia are recognized as separate disorders but share many commonalities, which raises the question of whether they are the same disorder on different ends of a continuum. The lack of distinct endophenotypes of bipolar......
Subject: Schizophrenia
Price: $3.00
*
New Study on Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII Shows Administration of Vyvanse Through Two Different Routes Demonstrated a Similar Pharmacokinetic Profile
2009 NOV 2 ... or when administered orally. Specifically, the overall rate and extent of exposure to d-amphetamine, the active medication in Vyvanse, was similar in healthy adults whether they received ...
Subject: Pharmacokinetics
Price: $3.00
*
Report summarizes schizophrenia study findings from Tel-Aviv University
2009 NOV 23 -- "Epidemiological and clinical life cycle studies have indicated that the more favorable illness course and the better response to antipsychotic drugs (APDs) in women with schizophrenia correlate with high levels of estrogen, whereas increased......
Subject: Schizophrenia
Price: $3.00
*
Reports from M.B. Haffey et al highlight recent research in pharmacokinetics
2009 NOV 23 ... Overall, 24 subjects were randomized; 21 completed the study. For LDX monotherapy, d-amphetamine mean (SD) exposure was 45.0 (13.97) ng/mL and 713.0 (134.75) ng. h/mL; when ...
Subject: Pharmacokinetics
Price: $3.00
*
Reports from W. Adams and colleagues advance knowledge in schizophrenia
2009 NOV 23 ... by ketamine, cocaine, 3,4-methylenedioxymethampethamine (MDMA), methamphetamine, and d-amphetamine. Male Sprague-Dawley rats were bilaterally microinjected with vehicle or the ...
Subject: Schizophrenia
Price: $3.00
*
Research from University of Utrecht yields new findings on psychopharmacology
2009 NOV 28 ... to antagonize hyperlocomotion induced by dopamine agonists, such as the psychostimulant d-amphetamine. However, the substantial differences between rodents and humans may hinder ...
Subject: Psychopharmacology
Price: $3.00
*
Research in the area of schizophrenia therapy reported from Polish Academy of Sciences, Pharmacology Department
2009 NOV 23 -- A new study, '1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and......
Subject: Schizophrenia Therapy
Price: $3.00
*
Research reports from Keio University, Medical Department provide new insights into parkinsonian disorders
2009 NOV 16 -- Researchers in Tokyo, Japan conducted a study "To physiologically repair damaged neural circuitry using neural transplantation, the donor cells must be able to differentiate into the optimal type and number of neurons for the host brain......
Subject: Parkinsonian Disorders
Price: $3.00
*
Research results from Michigan State University update knowledge of proteomics
2009 NOV 23 -- According to a study from the United States, "We demonstrated previously a negative association of granulosa cell cocaine- and amphetamine-regulated transcript (CARTPT) expression with follicle health status and inhibitory effects of the mature......
Subject: Proteomics
Price: $3.00
*
Researchers from University of California report details of new studies and findings in the area of sleep deprivation
2009 NOV 24 -- "Sleep has been suggested to play a role in memory consolidation. Prior rodent studies have used sleep deprivation to examine this relationship," researchers in the United States report.    "First, we reexamined the effects of sleep......
Subject: Sleep Deprivation
Price: $3.00
*
Studies conducted at Mental Health Research Institute on schizophrenia therapy recently published
2009 NOV 2 -- A report, 'Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation,' is newly published data in The International Journal of......
Subject: Schizophrenia Therapy
Price: $3.00
*
Studies from University of Washington add new findings in the area of behavior
2009 NOV 9 -- New research, 'Pairing mild stress with increased serotonin-1B receptor expression in the nucleus accumbens increases susceptibility to amphetamine,' is the subject of a report. According to a study from the United States, "Both serotonin-1B......
Subject: Behavior
Price: $3.00
*
Study results from Harvard University provide new insights into pharmaceuticals
2009 NOV 16 -- According to recent research from the United States, "Cocaine addiction is a worldwide public health problem for which there are no established treatments. The dopamine transporter (DAT) is suspected as the primary target mediating cocaine's......
Subject: Pharmaceuticals
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login